-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lixadesiran + Pixofisiran in Basal Cell Carcinoma (Basal Cell Epithelioma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lixadesiran + Pixofisiran in Basal Cell Carcinoma (Basal Cell Epithelioma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lixadesiran + Pixofisiran in Basal...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AMX-3009 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. AMX-3009 in Solid Tumor Drug Details: AMX-3009 is under development for the treatment of HER2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Gedeptin in Recurrent Head And Neck Cancer Squamous Cell Carcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Gedeptin in Recurrent Head And Neck Cancer Squamous Cell Carcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Gedeptin in Recurrent Head And Neck...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – BI-1810631 in Bile Duct Cancer (Cholangiocarcinoma)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BI-1810631 in Bile Duct Cancer (Cholangiocarcinoma) Drug Details: BI-1810631 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STP-122G in Bleeding And Clotting Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STP-122G in Bleeding And Clotting Disorders report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STP-122G in Bleeding And Clotting Disorders Drug Details: STP-122G...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STP-122G in Thrombosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STP-122G in Thrombosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. STP-122G in Thrombosis Drug Details: STP-122G is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lazucirnon Hydrochloride in Inflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lazucirnon Hydrochloride in Inflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lazucirnon Hydrochloride in InflammationDrug Details:Lazucirnon hydrochloride (ALK-4290) is under development for the treatment...
-
Product Insights
Net Present Value Model: Gedeptin
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Gedeptin Drug Details Gedeptin (Ad/PNP-F-araAMP) is...
-
Product Insights
Net Present Value Model: V-116
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model V-116 Drug Details Vaccine is under...